RKDA · Arcadia Biosciences, Inc.
$0.48
-0.14 (-23.12%)
At close · Aug 17
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We believe that our existing cash and cash equivalents will not be sufficient to meet our anticipated cash requirements for at least the next 12 months from the issuance date of these condensed consolidated financial statements, which raises substantial doubt about the Company's ability to continue as a going concern, and the audit opinion on our 2025 audited consolidated financial statements includes a going concern explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.50M
Shares
2.41M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding RKDA
4 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | — | 27,879 | $26,900 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 9,644 | $13,309 | 0.00% | Long | 2026-03-31 | |
| Fidelity Series Total Market Index Fund | — | 1,716 | $1,656 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | — | 1,626 | $1,569 | 0.00% | Long | 2026-05-31 |
Showing 1–4 of 4 positions